Toxoplasmosis, Parvovirus, and Cytomegalovirus in Pregnancy

被引：18
作者：
Feldman, Deborah M. [1 ]
Timms, Diane [2 ]
Borgida, Adam F. [1 ]
机构：
[1] Univ Connecticut, Div Maternal Fetal Med, Dept Obstet & Gynecol, Prenatal Testing Ctr,Sch Med,Hartford Hosp, Hartford, CT 06102 USA
[2] Univ Connecticut, Sch Med, Dept Obstet & Gynecol, Maternal Fetal Med,UConn Hlth Ctr, Farmington, CT 06030 USA
来源：
CLINICS IN LABORATORY MEDICINE | 2010年 / 30卷 / 03期
关键词：
Toxoplasmosis; Parvovirus; Cytomegalovirus; Diagnosis; Management; PRENATAL-DIAGNOSIS; IMMUNOGLOBULIN-M; CONGENITAL TOXOPLASMOSIS; MATERNAL INFECTION; NONIMMUNE HYDROPS; GONDII INFECTION; B19; INFECTION; PREVENTION; MANAGEMENT; AVIDITY;
D O I：
10.1016/j.cll.2010.04.009
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Several infections in adults warrant special consideration in pregnant women given the potential fetal consequences. Among these are toxoplasmosis, parvovirus B19, and cytomegalovirus. These infections have an important effect on the developing fetus depending on the timing of infection. This article reviews the modes of transmission as well as maternal and neonatal effects of each of these infections. In addition, recommended testing, fetal surveillance, and treatment where indicated are outlined.
引用
收藏
页码：709 / +
页数：13
相关论文
共 58 条
[1]   DETECTION OF ANTIBODIES AND ANTIGENS OF HUMAN PARVOVIRUS B19 BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
ANDERSON, LJ ;
TSOU, C ;
PARKER, RA ;
CHORBA, TL ;
WULFF, H ;
TATTERSALL, P ;
MORTIMER, PP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (04) :522-526
[2]  
[Anonymous], 2000, MMWR MORBMORTAL WKLY
[3]  
Bachmeyer C, 2006, J Infect, V52, pe55, DOI 10.1016/j.jinf.2005.05.004
[4]   Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis [J].
Bessieres, M. H. ;
Berrebi, A. ;
Cassaing, S. ;
Fillaux, J. ;
Cambus, J. P. ;
Berry, A. ;
Assouline, C. ;
Ayoubi, J. M. ;
Magnaval, J. F. .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (02) :389-392
[5]   SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS-INFECTION - NEONATAL MORBIDITY AND MORTALITY [J].
BOPPANA, SB ;
PASS, RF ;
BRITT, WJ ;
STAGNO, S ;
ALFORD, CA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (02) :93-99
[6]   Middle Cerebral Artery Peak Systolic Velocity and Ductus Venosus Velocity in the Investigation of Nonimmune Hydrops [J].
Borna, Sedigheh ;
Mirzaie, Fatemeh ;
Hanthoush-Zadeh, Sedigheh ;
Khazardoost, Soghra ;
Rahimi-Sharbaf, Fatemeh .
JOURNAL OF CLINICAL ULTRASOUND, 2009, 37 (07) :385-388
[7]   Prevention of toxoplasmosis during pregnancy - an epidemiologic survey over 22 consecutive years [J].
Breugelmans, M ;
Naessens, A ;
Foulon, W .
JOURNAL OF PERINATAL MEDICINE, 2004, 32 (03) :211-214
[8]   Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis [J].
Cahill, Alison G. ;
Odibo, Anthony O. ;
Stamilio, David M. ;
Macones, George A. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (05) :466.e1-466.e7
[9]   THE ROLE OF PARVOVIRUS-B19 IN APLASTIC CRISIS AND ERYTHEMA INFECTIOSUM (5TH DISEASE) [J].
CHORBA, T ;
COCCIA, P ;
HOLMAN, RC ;
TATTERSALL, P ;
ANDERSON, LJ ;
SUDMAN, J ;
YOUNG, NS ;
KURCZYNSKI, E ;
SAARINEN, UM ;
MOIR, R ;
LAWRENCE, DN ;
JASON, JM ;
EVATT, B .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) :383-393
[10]   USE OF ANTIPROTOZOAN AND ANTHELMINTIC DRUGS DURING PREGNANCY - SIDE-EFFECTS AND CONTRAINDICATIONS [J].
COOK, GC .
JOURNAL OF INFECTION, 1992, 25 (01) :1-9
123456